Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8468843 | 0.79 | NPSR1 (0.32) | NPSR1HTTALDH1A1 | |
| SCHEMBL7779537 | 0.75 | KDM4E (0.37) | KDM4EPKM | |
| SCHEMBL28761978 | 0.73 | ALDH1A1 (0.34) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| SCHEMBL299428 | 0.73 | ALDH1A1 (0.38) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| Iodide SCHEMBL27948774 | 0.72 | HTT (0.37) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL27948654 | 0.72 | HTT (0.37) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| Fluoride SCHEMBL27932970 | 0.70 | ALDH1A1 (0.36) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| SCHEMBL16667155 | 0.70 | MAOA (0.42) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| Iodide SCHEMBL27933050 | 0.70 | ALDH1A1 (0.36) | SIGMAR1NPSR1HTTALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL27933256 | 0.70 | ALDH1A1 (0.36) | SIGMAR1NPSR1HTTALDH1A1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1787971-A2 | Process for preparing aryl allyl ethers | Dow Gloval Technologies Inc. (US) | 2007-05-23 | — | — | EP | disclosed |
| EP-1546078-A1 | PROCESS FOR PREPARING ARYL ALLYL ETHERS | Dow Global Technologies Inc. (US) | 2005-06-29 | — | — | EP | disclosed |
| US-20050033094-A1 | Process for preparing aryl allyl ethers | BORIACK CLINTON J (US) | 2005-02-10 | — | — | US | disclosed |
| EP-1080084-B1 | PROCESS FOR EPOXIDATION OF ARYL ALLYL ETHERS | DOW GLOBAL TECHNOLOGIES INC (US) | 2004-05-06 | — | — | EP | disclosed |
| WO-2004013076-A1 | PROCESS FOR PREPARING ARYL ALLYL ETHERS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20040024263-A1 | Process for preparing aryl allyl ethers | BORIACK CLINTON J (US) | 2004-02-05 | — | — | US | disclosed |
| CN-1303382-A | Epoxidation process for aryl allyl ethers | DOW CHEMICAL CO (US) | 2001-07-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024263-A1 | Process for preparing aryl allyl ethers | PICALM, AP2M1, AP1M1 | SIGMAR1 662/4885NPSR1 1495/4885HTT 3836/4885 |
| US-20050033094-A1 | Process for preparing aryl allyl ethers | PICALM, AP2M1, AP1M1 | SIGMAR1 662/4885NPSR1 1495/4885HTT 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.